OAJ
INSY

Ogorek Anthony Joseph’s Insys Therapeutics, Inc. INSY Stock Holding History

Ogorek Anthony Joseph’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-150
Closed -$1K – 74
2017
Q2 		$1K Hold
150
– – ﹤0.01% 61
2017
Q1 		$1K Hold
150
– – ﹤0.01% 60
2016
Q4 		$1K Hold
150
– – ﹤0.01% 67
2016
Q3 		$1K Buy
+150
New +$2.28K ﹤0.01% 67

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ogorek Anthony Joseph's INSY Position: Q3 2017 in Review

Ogorek Anthony Joseph sold out of Insys Therapeutics, Inc. (INSY) in Q3 2017, closing a stake of 150 shares — an estimated $1K sold.

Ogorek Anthony Joseph first reported a position in INSY in Q3 2016 and held it in 4 quarters. The position peaked at $1K in Q2 2017. 116 funds tracked by Wall St. Rank hold INSY as of Q3 2017.

  • Ogorek Anthony Joseph reported no remaining Insys Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Ogorek Anthony Joseph sold 150 Insys Therapeutics, Inc. shares in Q3 2017, an estimated $1K.
  • Ogorek Anthony Joseph first reported a position in Insys Therapeutics, Inc. in Q3 2016 and held it in 4 quarters.
  • Ogorek Anthony Joseph's Insys Therapeutics, Inc. position peaked at $1K in Q2 2017.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2017.

Based on Ogorek Anthony Joseph's 13F filing for Q3 2017, filed 25 Oct 2017.